Submission of the manuscript is online via e-mail
ecgarticle@gmail.com or
cholerez@mail.ru

Tel: +7 903 250 5288

Editorial Correspondence e-mail
gastrossr@gmail.com


Publishing, Subscriptions, Sales and Advertising, Correspondence e-mail
journal@cniig.ru

Tel: +7 917 561 9505

SCImago Journal & Country Rank

    1. Institute of Biology, Chemistry and Bioresources of Chernovtsi national university named by Yurii Fedkovych, Biochemistry and biotechnology department (Chernivtsi, Ukraine)

    Keywords:acetaminophen-induced hepatitis,alimentary deprivation of protein,indicators of hemostasis system

    Abstract:The hemostasis system indicators of rats with acetaminophen-induced hepatitis under the conditions of alimentary deprivation of protein were assessed in the research. Research was conducted on 4 groups of animals: 1 - control; 2 - rats maintained on low-protein diet; 3 - rats with acute acetaminophen-induced hepatitis, maintained on full-value ration, 4 - rats with acute acetaminophen-induced hepatitis, maintained under the conditions of alimentary deprivation of protein. The activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and fibrinogen concentration were determined by optical method on a semi-automated coagulometer HUMACLOT Junior (Human GmbH, Germany). The content of soluble fibrin-monomer complexes (SFMC) was assessed using the “RFMK test” test system; the serum D-dimer concentration was determined by enzyme immunoassay. Our study established an increase of prothrombin time in protein-deficient animals, while in other parameters of the hemostasis system significant changes were not detected. Meanwhile, a significant increase of APTT, prothrombin and thrombin time is established in animals with acetaminophen-induced hepatitis. At the same time, the results of this study suggest that the accumulation of blood fibrinogen and SFMC is higher in almost 3 and 1.5 times respectively compared to control values, on the background of maintaining of the D-dimer concentration at the control level. The most pronounced changes of hemostatic system are observed in animals with toxic liver damage, which contained on a low protein diet. A decrease of procoagulant blood potential was established in rats of this group that was shown by increase of APTT, prothrombin time and also of hyperfibrinogenemia on the background of the accumulation of SFMC. In conclusion, acetaminophen-induced liver damage is accompanied by disorders of the hemostasis system, which are most pronounced in protein-deficient animals. The established elongation of APTT, PT, TT and the increasing of fibrinogen and SFMC contents indicate the formation of the hypocoagulation state and risk of hemorrhage. The results of the research can be used for biochemically substantiate and the development of optimal strategy for the correction of coagulopathies as consequences of toxic liver damage..

      1. Potze W., Porte R. J., Lisman Т. Management of coagulation Abnormalities in liver disease // Expert Review of Gastroenterology & Hepatology. - 2015. - Vol. 9, № 1. - Р. 103-114.
      2. Tripathi G.K., Katara A. A., Awasthi S. V., Srivastava S. V. Correlation of coagulation profile in liver disease patients in a tertiary care hospital // Int J Cur Res Rev. - 2016. - Vol. 8, № 8. - P. 1-3.
      3. Schadena E., Sanerb F. H., Goerlinger K. Coagulation pattern in critical liver dysfunction // Curr Opin Crit Care. -2013. - Vol. 19. - P. 19:00-0000 DOI:10.1097/MCC.0b013e32835ebb52.
      4. Lisman Т., Kwaan H. C. Hemostatic Dysfunction in Liver Diseases // Semin Thromb Hemost. - 2015. - Vol. 41, № 5. - Р. 445-446.
      5. Lisman Т., Caldwell S. H., Burroughs А. К. et al. Hemostasis and thrombosis in patients with liver disease: The ups and downs // Journal of Hepatology. - 2010. - Vol. 53. - P. 362-371.
      6. Andriulli A., Tripodi A., Angeli P. et al. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference // Digestive and Liver Disease. - 2016. - Vol. 48. - P. 455-467.
      7. Northup P.G., Caldwell S. H. Coagulation in Liver Disease: A Guide for the Clinician // Сlinical gastroenterology and hepatology. - 2013. - Vol. 11. - Р. 1064-1074.
      8. Lisman T., Porte R. J. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences // Blood. - 2010. - Vol. 116. - P. 878-885.
      9. Voloshchuk O. N., Kopylchuk G. P., Badyak O. D. Activity Of The Liver Malate-Aspartate Shuttle Mitochondrial Enzymes In Rats Under The Conditions Of Alimentary Deficiency Of Protein. Fundamental medicine and biology. 2014;83 (3). p. 12–16.
      10. Voloshchuk O.N., Kopylchuk G. P. The Peculiarities of the Structural and Functional State of the Cytochrome Component of the Liver Mitochondrial Respiratory Chain under Conditions of Acetaminophen-Induced Hepatitis on the Background of Alimentary Protein Deprivation // Biophysics. - 2015. - Vol. 60, № 3. - Р. 420-424.
      11. Devrajani B.R., Talpur M. A.A., Atta-ur-Rahman A. et al. Coagulopathies in Patients with Liver Cirrhosis // World Applied Sciences Journal. - 2012. - Vol. 17, № (1). - P. 01-04.
      12. Tripodi A., Caldwell S. H., Hoffman M. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease // Aliment Pharmacol Ther. - 2007. - Vol. 26. - P. 141-148.
      13. Shah S.N., Trupti J. Coagulation profile in liver disease-a study of 100 cases // Gujarat medical journal. - 2014. - Vol. 69, № 1. - P. 37-40.
      14. Kopylchuk G. P., Voloshchuk O. N. Modeling of the acetaminophen-induced disturbances of the bile producing liver function under the conditions of alimentary deprivation of protein. Biomedicine. 2015;№2. p. 30–36.
      15. Voloshchuk O.N., Kopyl’chuk G.P., Buchkovskaia I. M. Activity of the marker liver enzymes under the conditions of toxic hepatitis and alimentary deprivation of protein // Experimental & clinical gastroenterology. - 2014. - Vol. 108, № 8. - P. 96-100.
      16. Sajaa M.F., Abdob A. A., Sana F. M. et al. The coagulopathy of liver disease: does vitamin K help? // Blood Coagulation and Fibrinolysis. - 2013. - Vol. 24, № 1. - P. 10-17.
      17. Groeneveld D.J., Adelmeijer J., Hugenholtz G. C.G. et al. Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation // Journal of Thrombosis and Haemostasis. - 2015. - Vol. 13. - P. 2192-2201.
      18. Tennent G.A., Brennan S. O., Stangou A. J. et al. Human plasma fibrinogen is synthesized in the liver // Blood. - 2007. - Vol. 109, № 5. - P. 1971-1974.
      19. Tripodi A. D-Dimer Testing in Laboratory Practice // Clinical Chemistry. - 2011. - Vol. 57, № 9. - P. 1256-1262.
     


    Full text is published :
    THE STATE OF HEMOSTASIS SYSTEM IN RATS WITH TOXIC HEPATITIS UNDER THE CONDITIONS OF ALIMENTARY DEPRIVATION OF PROTEIN. Experimental and Clinical Gastroenterology Journal. 2018;150(02):82-88
    Read & Download full text